Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2296 to 2310 of 9026 results

  1. Nicardipine (Nicaplant) for aneurysmal subarachnoid haemorrhage patients undergoing aneurysm clipping [TSID10593]

    Awaiting development Reference number: GID-TA10957 Expected publication date: TBC

  2. Dulaglutide for treating type 2 diabetes [ID1451]

    Awaiting development Reference number: GID-TA10439 Expected publication date: TBC

  3. Omecamtiv mecarbil for treating chronic heart failure with reduced ejection fraction [ID3912]

    Awaiting development Reference number: GID-TA10797 Expected publication date: TBC

  4. Heart valve disease in adults

    Awaiting development Reference number: GID-QS10101 Expected publication date: TBC

  5. Adrenal dysfunction

    Awaiting development Reference number: GID-QS10038 Expected publication date: TBC

  6. Fianlimab with cemiplimab for untreated unresectable advanced melanoma or adjuvant treatment of completely resected high-risk melanoma [ID6721]

    Awaiting development Reference number: GID-TA11929 Expected publication date: TBC

  7. Neuromodulation for chronic pelvic pain

    Topic prioritisation

  8. Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension

    Topic prioritisation

  9. Trans-septal transcatheter mitral valve-in-valve implantation for failed surgical mitral valve bioprosthesis

    Topic prioritisation

  10. PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes, (MT740)

    Topic prioritisation

  11. MT646 Bardy Carnation Ambulatory Monitor

    Topic prioritisation

  12. Zoll ThermoGuard XP for Intravascular Temperature Management

    Topic prioritisation

  13. PCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysms

    Topic prioritisation

  14. Evinacumab for treating homozygous familial hypercholesterolemia in children aged 6 months to 11 [TSID11806]

    Topic prioritisation

  15. Macitentant–tadalafil for treating pulmonary arterial hypertension [TSID10517]

    Topic prioritisation